SCHEMBL6435065

SCHEMBL6435065

[CH2]CC(O)CCCCCCC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 8/20 0.54
FFAR1 O14842 2/20 0.52
FFAR4 Q5NUL3 1/20 0.52
SPHK1 Q9NYA1 2/20 0.46
LMNA P02545 2/20 0.46
PSMD14 O00487 2/20 0.46
PLA2G1B P04054 2/20 0.46
MMP2 P08253 2/20 0.46
ATG4B Q9Y4P1 2/20 0.46
HSP90AA1 P07900 1/20 0.46
RAD52 P43351 1/20 0.46
NFKB1 P19838 1/20 0.45
CYP2D6 P10635 2/20 0.43
GMNN O75496 1/20 0.43
POLB P06746 1/20 0.43
THPO P40225 1/20 0.43
MTOR P42345 1/20 0.43
BLM P54132 1/20 0.43
KDM4E B2RXH2 1/20 0.43
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL350608 1.00 GPR84 (0.54) GPR84FFAR1FFAR4SPHK1LMNA
SCHEMBL8492038 1.00 GPR84 (0.54) GPR84FFAR1FFAR4SPHK1LMNA
SCHEMBL1543114 1.00 GPR84 (0.54) GPR84FFAR1FFAR4SPHK1LMNA
SCHEMBL1359315 1.00 GPR84 (0.54) GPR84FFAR1FFAR4SPHK1LMNA
SCHEMBL6434325 1.00 GPR84 (0.54) GPR84FFAR1FFAR4SPHK1LMNA
SCHEMBL3176674 1.00 GPR84 (0.54) GPR84FFAR1FFAR4SPHK1LMNA
SCHEMBL3171090 1.00 GPR84 (0.54) GPR84FFAR1FFAR4SPHK1LMNA
SCHEMBL4214622 1.00 GPR84 (0.54) GPR84FFAR1FFAR4SPHK1LMNA
SCHEMBL3167337 1.00 GPR84 (0.54) GPR84FFAR1FFAR4SPHK1LMNA
SCHEMBL28962373 1.00 GPR84 (0.54) GPR84FFAR1FFAR4SPHK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106497289-B A kind of stone cultural artifact protection preparation method of organic nano composite coating 洛阳理工学院 2018-12-21 CN claimed
CN-107141427-A A kind of photochromic composition and its application 无锡创彩光学材料有限公司 2017-09-08 CN claimed
CN-106497289-A A kind of preparation method of stone cultural artifact protection with organic nano composite coating 洛阳理工学院 2017-03-15 CN claimed
US-20240228799-A1 NON-HAZARDOUS MONOMERS AS REACTIVE DILUENTS FOR RESINS ELANTAS EUROPE GMBH (DE) 2024-07-11 US disclosed
EP-4337634-A1 NON-HAZARDOUS MONOMERS AS REACTIVE DILUENTS FOR RESINS Elantas Europe GmbH (DE) 2024-03-20 EP disclosed
US-20220202683-A1 INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL HENKEL AG & CO. KGAA (DE) 2022-06-30 US disclosed
EP-3946241-A1 INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL Henkel AG & Co. KGaA (DE) 2022-02-09 EP disclosed
CN-113677317-A Increasing the stability of agents for treating keratin materials 汉高股份有限及两合公司 2021-11-19 CN disclosed
WO-2020200546-A1 INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL HENKEL AG & CO. KGAA (DE) 2020-10-08 WO disclosed
CN-109504258-A A kind of production method with heat-insulated and super hydrophobic functional transparent car clothing 成都德科立高分子材料有限公司 2019-03-22 CN disclosed
CN-108672095-A γ-hydroxy alkyl hydroximic acid and the preparation method and application thereof 广东省资源综合利用研究所 2018-10-19 CN disclosed
US-20020054991-A1 Thermoplastic resin film satisfactory in printability YUPO CORPORATION (JP) 2002-05-09 US disclosed
EP-1172400-A1 THERMOPLASTIC RESIN FILM WITH SATISFACTORY PRINTABILITY Yupo Corporation (JP) 2002-01-16 EP disclosed
US-4122282-A PROSTAGLANDINS THE UPJOHN COMPANY (US) 1978-10-24 US disclosed
US-4099014-A BLOOD PLATELET AGGREGATION INHIBITORS THE UPJOHN COMPANY (US) 1978-07-04 US disclosed
US-4085139-A PROSTAGLANDINS THE UPJOHN COMPANY (US) 1978-04-18 US disclosed
US-4081478-A PROSTAGLANDINS THE UPJOHN COMPANY (US) 1978-03-28 US disclosed
US-4073808-A PROSTAGLANDINS THE UPJOHN COMPANY (US) 1978-02-14 US disclosed
US-4033989-A 9-Deoxy-PGF2 Analogs THE UPJOHN COMPANY (US) 1977-07-05 US disclosed
US-4016184-A PROSTAGLANDINS, BLOOD PLATELET AGGREGATION INHIBITORS THE UPJOHN COMPANY (US) 1977-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220202683-A1 INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL KRT18, CCNO, AKR1B10 GPR84 2937/4885FFAR1 3516/4885FFAR4 4753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.